Evaluating coronary re-engagement after TAVR with a Navitor valve
COronary Re-EngageMent aFter RandOm NavitoR Alignment (COMFORT STUDY)
This study is testing if a new way of placing a heart valve during TAVR can help doctors still access the coronary arteries for patients who have both aortic stenosis and coronary artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Niguarda Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Milan, Lombardy) |
| Trial ID | NCT05779787 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the feasibility of coronary re-engagement following the implantation of a Navitor valve during Transcatheter Aortic Valve Replacement (TAVR) procedures. It aims to determine whether a random implantation technique can maintain effective access to coronary arteries, which is crucial for patients with pre-existing coronary artery disease. The study will assess the outcomes of patients with severe symptomatic aortic stenosis who undergo TAVR, focusing on the procedural complexity and the potential for unplanned coronary interventions. By comparing aligned versus random valve placements, the study seeks to provide insights into optimizing TAVR procedures for better patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are patients with severe, symptomatic aortic stenosis who are indicated for TAVI.
Not a fit: Patients who have undergone a Valve in Valve procedure or have hemodynamical instability will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could simplify TAVR procedures and improve access to coronary interventions for patients with aortic stenosis.
How similar studies have performed: While the approach of using commissural alignment techniques is emerging, this specific study's methodology is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Patients to be included in this registry should have all the following criteria: 1\. Severe, symptomatic aortic stenosis with an indication to TAVI Exclusion criteria and definition Patients excluded in this registry should have all the following criteria: 1. Valve in Valve procedure 2. Hemodynamical instability 3. TAVR performed from other access (not femoral) 4. No-CT Planned TAVR 5. TAVR performed with Chimney Technique
Where this trial is running
Milan, Lombardy
- ASST GOM Niguarda — Milan, Lombardy, Italy (Recruiting)
Study contacts
- Study coordinator: Giuseooe Esposito, MD
- Email: giuseppe.esposito@yahoo.com
- Phone: +393278393131
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.